Download the graphic [PDF: 1 page] showing the timeline of key landmarks for MMV-supported medicines.
2018
Rectal artesunate
Partners: Cipla/Strides Shasun
Added to the WHO list of Prequalified Medicinal Products
Krintafel/Kozenis
Trademarks owned or licensed by GSK
Partner: GSK
Approved by US FDA & Australian TGA
2016
Pyramax® granules
Partner: Shing Poong
Added to the WHO list of Prequalified Medicinal Products
Sulfadoxine-pyrimethamine + amodiaquine (SP+AQ)TM dispersible
Partner: Guilin Pharmaceutical
Global Fund Expert Review Panel reviewed product
2015
Pyramax granules
Partner: Shin Poong
Received positive scientific opinion from EMA
Pyramax tablets
Partner: Shin Poong
EMA authorized expanded use for patients >20kg
Eurartesim®
Partner: Sigma-Tau
Added to the WHO list of Prequalified Medicinal Products
2014
Sulfadoxine-pyrimethamine + amodiaquine (SP+AQ)TM
Partner: Guilin Pharmaceutical
Added to the WHO list of Prequalified Medicinal Products
2012
Pyramax tablets
Partner: Shin Poong
Received positive scientific opinion from EMA
Pyramax tablets
Partner: Shin Poong
Added to the WHO list of Prequalified Medicinal Products
2011
Eurartesim®
Partner: Sigma-Tau
Received marketing authorization from EMA
2010
Artesun®
Patner: Guilin Pharmaceutical
Added to the WHO list of Prequalified Medicinal Products
2008
Coartem® Dispersible
Partner: Novartis
Approved by Swissmedic
Last updated October 2018